Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ArmaGen receives rare pediatric disease designation from FDA for AGT-181

Nov. 6, 2015

Volanesorsen lowers triglycerides in patients with familial chylomicronemia syndrome

Nov. 6, 2015

Novo Nordisk and University of Washington to investigate the brain's role in diabetes and obesity

Nov. 6, 2015

Sanofi and Hanmi partner to develop long-acting diabetes treatments

Nov. 5, 2015

CJ Healthcare presents GPR40 agonists

Nov. 5, 2015

Shanghai De Novo Pharmatech divulges SGLT2 inhibitors

Nov. 4, 2015

Aileron Therapeutics discloses PTH1R antagonists

Nov. 3, 2015

Chugai describes phase I candidate PTH1 receptor agonist PCO-371

Nov. 2, 2015

Ferring's Rekovelle MAA filing accepted by EMA

Nov. 2, 2015

Sanofi introduces GPR119 agonists

Nov. 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...